Literature DB >> 24217605

Role of uPA/uPAR in the modulation of angiogenesis.

Nunzia Montuori1, Pia Ragno.   

Abstract

Blood vessels connect all districts of the body and allow blood oxygen and nutrients to reach every cell in the organism. Dysregulation of blood vessel formation or functionality is the origin of a large number of diseases. During new vessel formation, endothelial cells degrade their basement membrane, migrate into the interstitial matrix and proliferate. Migrating endothelial cells need to be polarized, to focus at their leading edge the proteolytic machinery, which is essential for extracellular matrix degradation; thus, proteases and their receptors play a crucial role in angiogenesis. The urokinase-mediated plasminogen activation system is a complex system of serine proteases strongly involved in angiogenesis. The plasminogen activation system includes plasminogen/plasmin, activators, inhibitors and cell receptors. In the last decades, a large body of evidence has clearly indicated that the role of this system is not limited to extracellular matrix proteolysis but can contribute to all phases of the angiogenic process.
Copyright © 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217605     DOI: 10.1159/000353310

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  23 in total

1.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

2.  Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.

Authors:  Sudha Swamynathan; Chelsea L Loughner; Shivalingappa K Swamynathan
Journal:  Exp Eye Res       Date:  2017-08-10       Impact factor: 3.467

Review 3.  Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Authors:  Dorothee Hielscher; Constanze Kaebisch; Benedikt Julius Valentin Braun; Kevin Gray; Edda Tobiasch
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

4.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

5.  Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma.

Authors:  Elena Andreucci; Francesca Bianchini; Alessio Biagioni; Mario Del Rosso; Laura Papucci; Nicola Schiavone; Lucia Magnelli
Journal:  J Mol Med (Berl)       Date:  2016-08-24       Impact factor: 4.599

6.  Development of MicroRNA-146a-Enriched Stem Cell Secretome for Wound-Healing Applications.

Authors:  Renae Waters; Siddharth Subham; Settimio Pacelli; Saman Modaresi; Aparna R Chakravarti; Arghya Paul
Journal:  Mol Pharm       Date:  2019-08-26       Impact factor: 4.939

Review 7.  Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.

Authors:  Anna Laurenzana; Gabriella Fibbi; Anastasia Chillà; Giancarlo Margheri; Tommaso Del Rosso; Elisabetta Rovida; Mario Del Rosso; Francesca Margheri
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

8.  Expression of uPAR in human trophoblast and its role in trophoblast invasion.

Authors:  Shuai Liu; Qin Zheng; Xin-Yuan Cui; Kui-Xing Dai; Xue-Song Yang; Fa-Sheng Li; Qiu Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.

Authors:  Xiufeng Liu; Xintong Liu; Suwen Sunchen; Meixia Liu; Chen Shen; Juanjuan Wu; Wanli Zhao; Boyang Yu; Jihua Liu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  TRIM24 promotes colorectal cancer cell progression via the Wnt/β-catenin signaling pathway activation.

Authors:  Hong Tian; Hongmei Zhao; Bo Qu; Xiaoli Chu; Xing Xin; Qingwei Zhang; Weizhou Li; Shida Yang
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.